If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
385.00    0.00 (0.00%)
Bid:
370.00
Ask:
400.00
Spread: 30.00 (8.108%)
Market Cap: £36.79m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Year end and COVID 19 trading update

1 May 2020 07:00

RNS Number : 5604L
Cropper(James) PLC
01 May 2020
 

1 May 2020

 

James Cropper plc

("James Cropper" or the "Company")

Year end and COVID 19 trading update

 

Further to its announcement of 24th March, James Cropper is pleased to provide an update on the expected outturn for the year to 28th March 2020 just ended and on our expectations for trading during the current year.

Year ended 28 March 2020

As a result of delivering on the growth strategies within each division, the Group produced a strong performance last year with positive growth in both revenue and profits. Market penetration and expansion has been achieved across the divisions. Adjusted pre-tax profits (excluding IAS 19 impact) are expected to be well ahead of market expectations for that period and in excess of £6m.

Current trading

During the current COVID 19 pandemic, the Company's priorities are the health and well-being of all employees globally, supporting our customers and managing our cash resources.

Whilst the Company was on track to continue growing, the impact from COVID 19 will have a negative effect on product demand in each of our divisions:

· Technical Fibre Products is likely to see a downturn as a result of a decline in the aerospace market; however, growth is continuing in clean technology markets such as fuel cell and wind energy. As a result, we expect demand will not be so significantly affected.

· James Cropper Paper is likely to be the most affected of our divisions in the short term, as end markets have been directly impacted by the global lockdown. As a niche speciality provider, we expect demand and growth to return to normal levels after markets settle post-pandemic.

· Despite the impact from COVID-19, we expect Colourform to grow year-on-year, however not to the levels anticipated initially.

Given the high levels of uncertainty, we are not reasonably able to forecast the impact on our operations and financial performance for the current fiscal year. The environment is subject to rapid change. Nevertheless, at present we are expecting that the course of the financial year will be as follows: the first quarter to June 2020 to incur a large negative impact and it will be loss making. During this period, the Company is making use of the Government's Coronavirus Job Retention Scheme to furlough more than 50% of staff in the UK operations. In the next two quarters, to December 2020, we expect still to see a negative effect and to continue to be loss-making, albeit with some recovery evident. For the final quarter to March 2021, we expect progressive recovery towards a more normalised situation and the Company anticipates being back into profitability. We continue to monitor new information as it becomes available and progress our planning accordingly.

 

 

 

Cash resources and future capex

The business is now, we believe, in an 18-24 month recovery period. The Company expects a hit to cash during 2020-2021over the period of the COVID-19 pandemic and as we return to more normal trading conditions. We have acted promptly to conserve cash and to implement immediate savings to shore up reserves, including announcing that the Board has decided not to pay a final dividend in respect of the year ending 28 March 2020. The Company presently has liquidity of over £12 million including cash and available overdraft facilities which, when taking into account the cash management actions being implemented, is expected to be sufficient to weather the COVID-19 crisis and the return to more normal trading conditions.

The Board, nevertheless, is also considering the funding of its capital expenditure plans post the COVID-19 crisis, which support the future growth of the business. Accordingly, it is in the early stages of discussions with its bank debt providers on potential future facilities.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

Enquiries:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

ENDS

 Shore Capital

Robert Finlay, Henry Willcocks

Anita Ghanekar, John More

Tel: + 44 (0) 207 408 4090

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEESRIIVII
Date   Source Headline
7th Jul 20267:00 amRNSNotice of Results & Investor Presentation
6th Jul 20267:00 amRNSAppointment of Nominated Adviser and Broker
2nd Jul 20267:00 amRNSDebt refinancing
14th Apr 20267:00 amRNSFull Year Trading Update
27th Mar 20262:50 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RCollaboration with Hexcel on Composite Recycling
5th Dec 20259:34 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSPCA Shareholdings
17th Nov 20257:00 amRNSInterim Results
5th Nov 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 20257:00 amRNSCorrection: PDMR and PCA Shareholdings
17th Oct 20254:12 pmRNSPDMR and PCA Shareholdings
15th Sep 20257:00 amRNSDirector/PDMR Shareholding
3rd Sep 20253:34 pmRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSGrant of Awards under Long-Term Incentive Plan
17th Jul 20257:00 amRNSFull Year Results
15th Jul 20257:00 amRNSNotice of Full Year Results
7th Jul 20257:00 amRNSTrading and Paper & Packaging Customer Update
23rd Jun 20257:00 amRNS-RRecording of Capital Markets Event Presentation
18th Jun 20257:00 amRNSStrategy Update and Capital Markets Event
9th Jun 20257:00 amRNSRevised Terms Agreed for UK Banking Facility
5th Jun 20257:00 amRNS-RNotice of Capital Markets Event
19th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSFull Year Trading Update
1st May 20259:14 amRNS€1.75m sale of non-core IP assets
1st Apr 20257:00 amRNS-RStrategic Collaboration with HOERBIGER
14th Feb 20253:32 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSPDMR and PCA Shareholding
30th Jan 20257:00 amRNSConfirmation of Chief Executive Officer Succession
7th Jan 20257:00 amRNSDirectorate Change
23rd Dec 20249:21 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSInterim Results
4th Nov 202412:03 pmRNSNotification of Major Holdings
1st Nov 20241:05 pmRNSNotice of Interim Results
29th Oct 20247:00 amRNSChief Executive Officer Succession
10th Oct 202410:14 amRNSDirector/PDMR Shareholding
8th Oct 20244:39 pmRNSDirector/PDMR Shareholding
10th Sep 20243:19 pmRNSGrant of Awards under Long-Term Incentive Plan
4th Sep 20244:32 pmRNSResult of Annual General Meeting
4th Sep 20247:00 amRNSAGM Trading Update
5th Aug 202411:56 amRNSNotice of Annual General Meeting
23rd Jul 20247:00 amRNSFull Year Results
22nd Jul 20249:43 amRNSDirectorate Changes
10th Jul 20247:00 amRNSNotice of Full Year Results
14th Jun 202411:00 amRNSAgreement of Bank Covenant Amendments
23rd May 20247:00 amRNSAppointment of MD, Advanced Materials
30th Apr 20247:00 amRNSFull Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.